The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Essex Woodlands Ix, Llc since 2018.
This trader's CIK number is 1652286.
At the time of last reporting, Essex Woodlands Ix, Llc was the 10% Owner of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT).
Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | VERO | 3,920,000 | $4,900,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | EYPT | 0 | $0 | 680,000 | $8,429,194 | 0 | $0 |
| 2018 | EYPT | 25,470,390 | $30,799,999 | 0 | $0 | 0 | $0 |
2. Eyepoint Pharmaceuticals, Inc. (EYPT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-15 | VERO | Buy | 3,920,000 | 1.25 | 4,900,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-30 | EYPT | Sale | 60,976 | 11.14 | 679,333 |
| 2023-08-31 | EYPT | Sale | 78,495 | 10.59 | 831,576 |
| 2023-08-28 | EYPT | Sale | 60,858 | 11.71 | 712,647 |
| 2023-08-29 | EYPT | Sale | 87,854 | 11.15 | 979,659 |
| 2023-08-24 | EYPT | Sale | 139,280 | 14.62 | 2,036,134 |
| 2023-08-25 | EYPT | Sale | 84,656 | 10.93 | 925,120 |
| 2023-08-22 | EYPT | Sale | 46,778 | 14.62 | 683,847 |
| 2023-08-23 | EYPT | Sale | 121,103 | 13.05 | 1,580,878 |
| 2018-06-25 | EYPT | Buy | 16,864,066 | 1.26 | 21,333,043 |
| 2018-03-28 | PSDV | Buy | 8,606,324 | 1.10 | 9,466,956 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Essex Woodlands Ix, Llc (10% Owner of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.